According to a new study, women who gain weight in adulthood face a greater lifetime risk of all types of breast cancer even if they do not take hormone replacement therapy after menopause. The findings the first ever of its kind are...

Nidhi Sharma - AHN Contributor Washington D.C. (AHN) – Just weeks after research appeared to rule out any connection in the short to medium term, a major U.S. study now suggests that long-term use of oestrogen-only hormone replacement therapy (HRT) does increase the risk of breast cancer....

HealthDay - THURSDAY, Feb. 16 (HealthDay News) -- When taken for more than five years, estrogen-progestin hormone replacement therapy (HRT) is associated with a more than two-fold higher risk of lobular breast cancer or tubular breast cancer, compared with the more common ductal breast cancer, Swedish researchers report.